Literature DB >> 23828229

miR-1 induces growth arrest and apoptosis in malignant mesothelioma.

Yue Xu1, Ming Zheng2, Robert E Merritt1, Joseph B Shrager3, Heather A Wakelee4, Robert A Kratzke5, Chuong D Hoang6.   

Abstract

BACKGROUND: We investigated microRNA expression profiles of malignant pleural mesothelioma (MPM) specimens to identify novel microRNA that are potentially involved in the oncogenic transformation of human pleural cells.
METHODS: microRNA microarray transcriptional profiling studies of 25 MPM primary tumors were performed. We used normal pleural tissue from an unmatched patient cohort as normal comparators. To confirm microarray data, we used real-time quantitative polymerase chain reaction. Representative cell lines H513 and H2052 were used in functional analyses of miR-1.
RESULTS: In addition to several novel MPM-associated microRNAs, we observed that the expression level of miR-1 was significantly lower in tumors as compared with normal pleural specimens. Subsequently, pre-miR of miR-1 was introduced into MPM cell lines to overexpress this microRNA. Phenotypic changes of these altered cells were assayed. The cellular proliferation rate was significantly inhibited after overexpression of miR-1. Early and late apoptosis was increased markedly in miR-1-transfected cell lines. Taken together, these data suggested that overexpression of miR-1 induced apoptosis in these MPM cell lines, acting as a tumor suppressor. We confirmed our observations by assessing in the transduced MPM cells cell cycle-related, proapoptotic, and antiapoptotic genes, which all showed coordinated, significant changes characteristic of the apoptotic phenotype.
CONCLUSIONS: Further investigation and validation of our microRNA database of MPM may elucidate previously unrecognized molecular pathways and/or mechanisms by identifying novel microRNAs that are involved in malignant transformation. Our study has now found miR-1 to be one of these MPM-associated microRNAs, with potential pathogenic and therapeutic significance.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23828229      PMCID: PMC4694093          DOI: 10.1378/chest.12-2770

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  39 in total

1.  BDNF-Akt-Bcl2 antiapoptotic signaling pathway is compromised in the brain of autistic subjects.

Authors:  Ashfaq M Sheikh; Mazhar Malik; Guang Wen; Abha Chauhan; Ved Chauhan; Cheng-Xin Gong; Fei Liu; William T Brown; Xiaohong Li
Journal:  J Neurosci Res       Date:  2010-09       Impact factor: 4.164

Review 2.  Targeting of mRNAs by multiple miRNAs: the next step.

Authors:  M E Peter
Journal:  Oncogene       Date:  2010-03-01       Impact factor: 9.867

Review 3.  Malignant mesothelioma: facts, myths, and hypotheses.

Authors:  Michele Carbone; Bevan H Ly; Ronald F Dodson; Ian Pagano; Paul T Morris; Umran A Dogan; Adi F Gazdar; Harvey I Pass; Haining Yang
Journal:  J Cell Physiol       Date:  2012-01       Impact factor: 6.384

4.  Reprogramming of miRNA networks in cancer and leukemia.

Authors:  Stefano Volinia; Marco Galasso; Stefan Costinean; Luca Tagliavini; Giacomo Gamberoni; Alessandra Drusco; Jlenia Marchesini; Nicoletta Mascellani; Maria Elena Sana; Ramzey Abu Jarour; Caroline Desponts; Michael Teitell; Raffaele Baffa; Rami Aqeilan; Marilena V Iorio; Cristian Taccioli; Ramiro Garzon; Gianpiero Di Leva; Muller Fabbri; Marco Catozzi; Maurizio Previati; Stefan Ambs; Tiziana Palumbo; Michela Garofalo; Angelo Veronese; Arianna Bottoni; Pierluigi Gasparini; Curtis C Harris; Rosa Visone; Yuri Pekarsky; Albert de la Chapelle; Mark Bloomston; Mary Dillhoff; Laura Z Rassenti; Thomas J Kipps; Kay Huebner; Flavia Pichiorri; Dido Lenze; Stefano Cairo; Marie-Annick Buendia; Pascal Pineau; Anne Dejean; Nicola Zanesi; Simona Rossi; George A Calin; Chang-Gong Liu; Jeff Palatini; Massimo Negrini; Andrea Vecchione; Anne Rosenberg; Carlo M Croce
Journal:  Genome Res       Date:  2010-05       Impact factor: 9.043

5.  Downregulated microRNAs in the differential diagnosis of malignant pleural mesothelioma.

Authors:  Gretchen V Gee; Devin C Koestler; Brock C Christensen; David J Sugarbaker; Donatella Ugolini; Giovanni P Ivaldi; Murray B Resnick; E Andres Houseman; Karl T Kelsey; Carmen J Marsit
Journal:  Int J Cancer       Date:  2010-12-15       Impact factor: 7.396

6.  MicroRNAs dysregulation in human malignant pleural mesothelioma.

Authors:  Veronica Balatti; Stefania Maniero; Manuela Ferracin; Angelo Veronese; Massimo Negrini; Gloria Ferrocci; Fernanda Martini; Mauro G Tognon
Journal:  J Thorac Oncol       Date:  2011-05       Impact factor: 15.609

7.  MiR-483-5p suppresses the proliferation of glioma cells via directly targeting ERK1.

Authors:  Li Wang; Ming Shi; Shuangxing Hou; Bojun Ding; Lijuan Liu; Xituan Ji; Jian Zhang; Yanchun Deng
Journal:  FEBS Lett       Date:  2012-03-27       Impact factor: 4.124

8.  MicroRNA expression variability in human cervical tissues.

Authors:  Patrícia M Pereira; João Paulo Marques; Ana R Soares; Laura Carreto; Manuel A S Santos
Journal:  PLoS One       Date:  2010-07-26       Impact factor: 3.240

9.  Novel molecular beacons to monitor microRNAs in non-small-cell lung cancer.

Authors:  Quan Yao; An-mei Zhang; Hu Ma; Sheng Lin; Xin-xin Wang; Jian-guo Sun; Zheng-tang Chen
Journal:  Mol Cell Probes       Date:  2012-07-10       Impact factor: 2.365

10.  The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosis.

Authors:  H E Gee; F M Buffa; C Camps; A Ramachandran; R Leek; M Taylor; M Patil; H Sheldon; G Betts; J Homer; C West; J Ragoussis; A L Harris
Journal:  Br J Cancer       Date:  2011-03-15       Impact factor: 7.640

View more
  16 in total

Review 1.  Diagnostic and prognostic biomarkers for malignant mesothelioma: an update.

Authors:  Zhongjian Chen; Giovanni Gaudino; Harvey I Pass; Michele Carbone; Haining Yang
Journal:  Transl Lung Cancer Res       Date:  2017-06

Review 2.  In vitro experimental models of mesothelioma revisited.

Authors:  Anand Singh; Nathanael Pruett; Chuong D Hoang
Journal:  Transl Lung Cancer Res       Date:  2017-06

Review 3.  Role of microRNAs in malignant mesothelioma.

Authors:  A Truini; S Coco; A Alama; C Genova; C Sini; M G Dal Bello; G Barletta; E Rijavec; G Burrafato; F Boccardo; F Grossi
Journal:  Cell Mol Life Sci       Date:  2014-02-23       Impact factor: 9.261

Review 4.  MicroRNAs in mesothelioma: from tumour suppressors and biomarkers to therapeutic targets.

Authors:  Glen Reid
Journal:  J Thorac Dis       Date:  2015-06       Impact factor: 2.895

5.  Surgical controversies in mesothelioma: MesoVATS addresses the role of surgical debulking.

Authors:  Chuong D Hoang
Journal:  Transl Lung Cancer Res       Date:  2016-02

6.  Ectopic expression of micro-RNA-1, 21 and 125a in peripheral blood immune cells is associated with chronic HBV infection.

Authors:  Mohammad Momeni; Gholamhossein Hassanshahi; Mohammad Kazemi Arababadi; Derek Kennedy
Journal:  Mol Biol Rep       Date:  2014-04-16       Impact factor: 2.316

7.  Excessive expression of miR-1a by statin causes skeletal injury through targeting mitogen-activated protein kinase kinase kinase 1.

Authors:  Chang-Ning Fu; Jia-Wen Song; Zhi-Peng Song; Qian-Wen Wang; Wen-Wu Bai; Tao Guo; Peng Li; Chao Liu; Shuang-Xi Wang; Bo Dong
Journal:  Aging (Albany NY)       Date:  2021-04-16       Impact factor: 5.682

8.  A novel link between FMR gene and the JNK pathway provides clues to possible role in malignant pleural mesothelioma.

Authors:  Ajay Srivastava
Journal:  FEBS Open Bio       Date:  2015-08-19       Impact factor: 2.693

Review 9.  Diagnostic value of microRNAs in asbestos exposure and malignant mesothelioma: systematic review and qualitative meta-analysis.

Authors:  Luigina Micolucci; Most Mauluda Akhtar; Fabiola Olivieri; Maria Rita Rippo; Antonio Domenico Procopio
Journal:  Oncotarget       Date:  2016-09-06

10.  Overexpression of micro ribonucleic acid-591 inhibits cell proliferation and invasion of malignant pleural mesothelioma cells.

Authors:  Shizhao Cheng; Yue Xu; Zhenliang Shi; Yongbin Lin; Chuong D Hoang; Xun Zhang
Journal:  Thorac Cancer       Date:  2016-01-31       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.